Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Climacteric ; 26(5): 437-444, 2023 10.
Artigo em Inglês | MEDLINE | ID: mdl-37017707

RESUMO

OBJECTIVE: This study aimed to evaluate the self-reported satisfaction of Spanish postmenopausal women currently treated for vulvovaginal atrophy (VVA) symptoms. METHODS: The CRETA (CRoss sectional European sTudy on Adherence) is a multicenter cross-sectional study conducted in 29 public and private hospitals in Spain, which enrolled postmenopausal women receiving treatment with ospemifene, local hormone therapy (HT) or vaginal moisturizers for VVA. After the prior informed consent of the patients, sociodemographic and treatment perception data were collected using a structured questionnaire. RESULTS: Among 752 women who completed the survey, the satisfaction score was significantly higher for the group treated with ospemifene (mean 8.3 ± 1.4) compared with the local HT group (7.2 ± 1.7) and the vaginal moisturizer group (6.5 ± 2.1) according to a 10-point Likert scale (p < 0.0001). Compared to vaginal moisturizers and local HT, participants treated with ospemifene reported the highest adherence (96.7% vs. 70.2% and 78.6%, respectively) and the lowest number of missed doses in the last month (0.6 ± 1.3 standard deviation [SD] vs. 3.5 ± 4.3 SD and 2.0 ± 2.8 SD, respectively) (p < 0.0001). Ospemifene was significantly perceived as easy to use (83.9% vs. 44.9% and 58.6%, respectively; p < 0.0001), efficacious in reducing the time to relieve symptoms (17.1% vs. 7.0% and 6.7%, p = 0.0005 and p = 0.0006, respectively) and convenient for sexual life (53.1% vs. 25.6% and 42.3%, p < 0.0001 and p = 0.0234, respectively). CONCLUSIONS: Among postmenopausal women with VVA, treatment with ospemifene has the most positive perceptions and the highest overall satisfaction level and could be an optimal therapeutic approach, maximizing patient adherence.


Assuntos
Dispareunia , Doenças Vaginais , Feminino , Humanos , Vagina/patologia , Estudos Transversais , Dispareunia/tratamento farmacológico , Tamoxifeno/uso terapêutico , Hormônios/uso terapêutico , Adesão à Medicação , Atrofia/tratamento farmacológico , Satisfação Pessoal , Vulva/patologia , Doenças Vaginais/tratamento farmacológico
2.
Pract Odontol ; 9(12): 31-2, 34-5, 1988 Dec.
Artigo em Espanhol | MEDLINE | ID: mdl-3272398

RESUMO

A study exposing the situation affecting the population of San Luis Potosí in central México, caused by dental fluorosis. Findings point to the need of implementing devices capable of regulating the concentrations of Fluorine ion (generating the efficient prevention of dental cavity incidence), to maintain them at optimal levels and without deletereal effects.


Assuntos
Fluoretação/efeitos adversos , Fluorose Dentária/epidemiologia , Humanos , México/epidemiologia , Projetos Piloto
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...